Durable Capital Partners LP Invests $19.25 Million in Outset Medical, Inc. $OM

Durable Capital Partners LP bought a new position in shares of Outset Medical, Inc. (NASDAQ:OM) in the 1st quarter, according to its most recent 13F filing with the SEC. The fund bought 1,740,216 shares of the company’s stock, valued at approximately $19,247,000. Durable Capital Partners LP owned 48.41% of Outset Medical at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the stock. TD Asset Management Inc bought a new position in shares of Outset Medical during the 1st quarter valued at about $589,000. Massachusetts Financial Services Co. MA bought a new position in shares of Outset Medical during the 1st quarter valued at about $9,293,000. T. Rowe Price Investment Management Inc. bought a new position in shares of Outset Medical during the 1st quarter valued at about $17,730,000. Two Sigma Investments LP lifted its holdings in shares of Outset Medical by 36.0% during the 4th quarter. Two Sigma Investments LP now owns 488,602 shares of the company’s stock valued at $542,000 after purchasing an additional 129,334 shares in the last quarter. Finally, Squarepoint Ops LLC bought a new position in shares of Outset Medical during the 4th quarter valued at about $174,000.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on OM. Scotiabank upgraded Outset Medical to a “strong-buy” rating in a report on Thursday, May 15th. Wall Street Zen upgraded Outset Medical from a “sell” rating to a “hold” rating in a report on Saturday, June 7th. BTIG Research set a $37.00 price objective on Outset Medical and gave the company a “buy” rating in a report on Monday, July 14th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and set a $22.00 price objective on shares of Outset Medical in a report on Tuesday, August 19th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $24.67.

Outset Medical Stock Down 0.1%

Shares of Outset Medical stock opened at $13.91 on Monday. The business’s 50 day simple moving average is $16.73 and its 200 day simple moving average is $14.71. Outset Medical, Inc. has a 52-week low of $5.85 and a 52-week high of $25.35. The firm has a market cap of $247.13 million, a PE ratio of -0.69 and a beta of 2.14. The company has a debt-to-equity ratio of 0.63, a quick ratio of 6.05 and a current ratio of 7.47.

Outset Medical Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.